- CO Ticker
- 🇺🇸 NYSE Exchange
- 1,196 Employees
- 💊 Health Care Sector
- 🚑 Health Care Providers & Services Industry
- Ting Zheng CEO
Analyst Recommendations
This chart is a recommendation for investors. To provide forecasts, analysts and brokers use companies' public financial reports and speak with their employees and clients. The end result is a solution that's marked on the chart, which shows analysts' opinions at different periods of time. Move your cursor to track on what the dates the recommendations changed.
Investors shouldn't only follow analyst recommendations. Forecasts should be used to supplement existing strategies and plans. Trading based on a recommendation chart is is considered bad practice. Analyst reports should only be used in conjunction with your own analytics.
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies such as cord blood transplants. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provide matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.